Onderzoeker
Tom Vanden Berghe
- Disciplines:Biofysica, Moleculaire en celbiologie, Laboratoriumgeneeskunde, Microbiologie, Systeembiologie, Plantenbiologie, Medicinale en biomoleculaire chemie
Affiliaties
- Vakgroep Biomedische Moleculaire Biologie (Departement)
Lid
Vanaf1 okt 1999 → Heden
Projecten
1 - 5 of 5
- Onderzoek naar de immunoregulatorische eigenschappen van ferroptose in experimentele kankermodellenVanaf1 nov 2020 → HedenFinanciering: FWO mandaten
- Therapeutische verkenning van loodferroptoseremmers bij multiple sclerose - subsidie 2020Vanaf1 jan 2020 → 30 jun 2021Financiering: Stichtingen, fondsen e.d. met wetenschappelijk oogmerk
- Therapeutische verkenning van loodferroptoseremmers bij multiple scleroseVanaf1 jan 2019 → 31 dec 2020Financiering: Stichtingen, fondsen e.d. met wetenschappelijk oogmerk
- Gebaseerde nanodeeltjes ferroptose inductie voor de behandeling van neuroblastoma en glioblastomaVanaf1 jan 2019 → 31 dec 2021Financiering: Stichtingen, fondsen e.d. met wetenschappelijk oogmerk
- Studie van de in vivo rol van effector caspasen in (patho-)fysiologische modelsystemen.Vanaf1 okt 2007 → 30 sep 2013Financiering: BOF - Andere acties, FWO mandaten
Publicaties
81 - 90 van 104
- cIAP1 and TAK1 protect cells from TNF-induced necrosis by preventing RIP1/RIP3-dependent reactive oxygen species production(2011)
Auteurs: Nele Vanlangenakker, Tom Vanden Berghe, Pieter Bogaert, Bram Laukens, K Zobel, K Deshayes, D Vucic, S Fulda, Peter Vandenabeele, Mathieu Bertrand
Pagina's: 656 - 665 - Dying for a cause: NETosis, mechanisms behind an antimicrobial cell death modality(2011)
Auteurs: Quinten Remijsen, TW Kuijpers, Ellen Wirawan, Saskia Lippens, Peter Vandenabeele, Tom Vanden Berghe
Pagina's: 581 - 588 - Role of caspase-7 during early involution of the Escherichia coli- or the Staphylococcus aureus-infected mammary gland(2010)
Auteurs: Koen Breyne, Dieter Demon, Tom Vanden Berghe, Peter Vandenabeele
Aantal pagina's: 1 - Molecular mechanisms of necroptosis: an ordered cellular explosion(2010)
Auteurs: Peter Vandenabeele, Lorenzo Galluzzi, Tom Vanden Berghe, Guido Kroemer
Pagina's: 700 - 714 - The role of the kinases RIP1 and RIP3 in TNF-induced necrosis(2010)
Auteurs: Peter Vandenabeele, Franky Van Herreweghe, Tom Vanden Berghe
- The mitochondrial serine protease HtrA2/Omi cleaves RIP1 during apoptosis of Ba/F3 cells induced by growth factor withdrawal(2010)
Auteurs: Ellen Wirawan, Mohamed Lamkanfi, Nele Festjens, Jelle Verspurten, Tom Vanden Berghe, Peter Vandenabeele
Pagina's: 421 - 433 - Necroptosis, necrosis and secondary necrosis converge on similar cellular disintegration features(2010)
Auteurs: Tom Vanden Berghe, Nele Vanlangenakker, Eef Parthoens, Wies Deckers, Michael Devos, Nele Festjens, Chris Guerin, UT Brunk, Wim Declercq, Peter Vandenabeele
Pagina's: 922 - 930 - Expression of calcium-sensing receptor in quail granulosa explants: a key to survival during folliculogenesis(2010)
Auteurs: Araceli Diez Fraile, Sylvie Mussche, Tom Vanden Berghe, Marc Espeel, Peter Vandenabeele
Pagina's: 890 - 899 - Caspase-mediated cleavage of Beclin-1 inactivates Beclin-1-induced autophagy and enhances apoptosis by promoting the release of proapoptotic factors from mitochondria(2010)
Auteurs: Ellen Wirawan, Kristof Kersse, Sigrid Cornelis, S Claerhout, Isabel Vanoverberghe, Ria Roelandt, Jelle Verspurten, P Agostinis, Tom Vanden Berghe, Saskia Lippens, et al.
- RIP Kinases at the Crossroads of Cell Death and Survival(2009)
Auteurs: Tom Vanden Berghe, Peter Vandenabeele
Pagina's: 229 - 232
Patenten
1 - 6 van 6
- COMPOUNDS FOR INHIBITING CELL DEATH (Inventor)
- COMPOUNDS FOR INHIBITING CELL DEATH (Inventor)
- 3,4-diaminobenzenesulfonamide derivatives for inhibiting cell death (Inventor)
- COMPOUNDS FOR INHIBITING CELL DEATH (Inventor)
- Targeting of Interleukin-1 and -18 in treatment of septic shock (Inventor)
- 3,4-diaminobenzenesulfonamide derivatives for inhibiting cell death (Inventor)